Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes.
Fukashi IshibashiMiki TaniguchiAiko KosakaHarumi UetakeMitra TavakoliPublished in: Diabetes care (2018)
Normalizing HbA1c in type 2 diabetes of short duration improves microvascular complications including neuropathy and nephropathy more effectively than standard GC but not retinopathy.